Concord, CA 的 非小細胞肺癌 臨床試驗
14 項針對 非小細胞肺癌 的研究正在 Concord（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
招募中3 期
- Kaiser Permanente-Walnut Creek, Walnut Creek · 距離 5 英里
- John Muir Medical Center-Walnut Creek, Walnut Creek · 距離 5 英里
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
招募中3 期
- Kaiser Permanente-Walnut Creek, Walnut Creek · 距離 5 英里
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
招募中3 期
- Local Institution - 0208, Pleasant Hill · 距離 3 英里
- BASS Cancer Center, Walnut Creek · 距離 5 英里
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
招募中3 期
- John Muir Health Clinical Research Center, Concord
- John Muir Health Cancer Center, Walnut Creek · 距離 5 英里
- John Muir Health Clinical Research Center, Walnut Creek · 距離 5 英里
- 還有 1 項
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
招募中2 期
- Kaiser Permanente Walnut Creek Medical Center, Walnut Creek · 距離 5 英里
- John Muir Health Clinical Research Center, Walnut Creek · 距離 5 英里
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
招募中3 期
- BASS Cancer Center, Walnut Creek · 距離 5 英里
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
招募中觀察性研究
- John Muir Health, Walnut Creek · 距離 5 英里
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
招募中2/3 期
- John Muir Clinical Research Center, Concord
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
招募中3 期
- Research Site, Walnut Creek · 距離 5 英里
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- BASS Cancer Center, Walnut Creek · 距離 5 英里
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
招募中3 期
- Research Site, Walnut Creek · 距離 5 英里
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
招募中2 期
- Kaiser Permanente-Walnut Creek, Walnut Creek · 距離 5 英里
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
招募中2/3 期
- Kaiser Permanente-Walnut Creek, Walnut Creek · 距離 5 英里
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中觀察性研究
- Kaiser Permanente-Walnut Creek, Walnut Creek · 距離 5 英里
- Contra Costa Regional Medical Center, Martinez · 距離 6 英里
- Contra Costa Regional Medical Center, Martinez · 距離 6 英里
其他城市的 非小細胞肺癌 試驗
- Houston, TX145 項研究
- New York City, NY121 項研究
- Arlington, VA104 項研究
- Nashville, TN97 項研究
- Boston, MA90 項研究
- Los Angeles, CA87 項研究
- St. Louis, MO73 項研究
- Chicago, IL61 項研究
- Baltimore, MD60 項研究
- San Antonio, TX59 項研究
- Columbus, OH57 項研究
- Washington, DC55 項研究
Concord 的其他研究
- 肥胖症18 項研究
- 過重16 項研究
- 重度憂鬱症12 項研究
- 第二型糖尿病10 項研究
- 乳癌9 項研究
- 肺癌9 項研究
- 偏頭痛8 項研究
- 癌症（所有類型）7 項研究
- 憂鬱症6 項研究
- 前列腺癌6 項研究
- 糖尿病5 項研究
- 阿茲海默症5 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。